-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 14, 2022, the team of Professor Dihua Yu from MD Anderson Cancer Center published a research paper titled: Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1 in the journal Cancer Discovery
Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1
Combining retrospective analysis of clinical records with laboratory studies, the research team found that vitamin E directly binds and blocks the immune checkpoint protein SHP1 in dendritic cells, thereby activating dendritic cell activity, enhancing antigen presentation and priming T cells.
The study suggests new approaches to improve cancer immunotherapy, including combination therapy with vitamin E, or direct targeting of SHP1, which inhibits dendritic cells
Novel approaches to improve cancer immunotherapy are proposed, including combination therapy with vitamin E, or direct targeting of SHP1 that inhibits dendritic cells
"This study broadens our understanding of factors that may influence immunotherapy response," said the study's corresponding author, Dihua Yu, a tenured professor at MD Anderson Cancer Center
Vitamin E linked to improved response to immunotherapy
Vitamin E is associated with improved response to immunotherapy Vitamin E is associated with improved response to immunotherapyImmune checkpoint inhibitors are a type of cancer immunotherapy developed in recent years and are considered to be a major breakthrough that has changed the landscape of cancer treatment
Immune checkpoint inhibitors can provide durable therapeutic responses in many cancer patients, but not all cancer patients benefit.
Dietary supplements are thought to boost immunity, but little is known about the effects of dietary supplements on immunotherapeutic activity
The research team found that patients with melanoma who received PD-1/PD-L1 immune checkpoint inhibitors were treated with PD-1/PD-L1 immune checkpoint inhibitors compared to those who did not take vitamin E or multivitamins.
This finding was validated in an independent mixed cohort of breast, colon, and kidney cancer patients
Next, the team found that vitamin E enhanced responses to immune checkpoint inhibitors in mouse models of breast cancer and melanoma
Deciphering the effects of vitamin E on dendritic cells
Deciphering the effects of vitamin E on dendritic cellsDendritic cells are a special type of immune cells that are responsible for presenting antigens to T cells, that is, they play an important role in antigen presentation, which is an important step in the anti-tumor immune response
The research team found that vitamin E treatment led to the upregulation of several activation markers on dendritic cells
Through molecular and structural studies, the research team found that vitamin E can enter dendritic cells and bind to its SHP1 protein.
Further studies have shown that inhibiting the SHP1 gene can mimic the results of vitamin E treatment, increase antigen presentation, and stimulate T cell anti-tumor immune responses
Targeting SHP1 may be a new therapeutic strategy
Targeting SHP1 may be a new therapeutic strategySince vitamin E appears to improve antigen presentation by dendritic cells, the research team further investigated whether vitamin E could enhance response to therapies known to release tumor antigens and recruit dendritic cell infiltration
Experimental results suggest that vitamin E treatment can enhance the efficacy of cancer vaccines and immunogenic chemotherapy in combination with checkpoint inhibitors, including the treatment of immunotherapy-resistant pancreatic cancer
Dr.
Xiangliang Yuan, the first author of the paper, said that SHP1 is an attractive target to efficiently activate dendritic cells for the development of effective immunotherapies
.
This study provides important insights into the interaction between vitamin E and SHP1, which will guide us to develop more specific SHP1 inhibitors, and reactivation of dendritic cell antigen presentation by inhibiting SHP1 may be effective in enhancing antitumor immunity.
strategy
.
It is reported that the research team is currently working with clinicians at MD Anderson Cancer Center to evaluate the effect of vitamin E in combination with immune checkpoint inhibitors and other immunotherapies
.
In addition, the research team is exploring opportunities to develop SHP1 inhibitors, as well as SHP1-silencing dendritic cells and dendritic cell-derived extracellular vesicles as new future therapeutic options
.
Original source:
Original source:Xiangliang Yuan, et al.
Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1 .
Cancer Discov candisc.
0900.
2021.
Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1 .
Cancer Discov candisc.
0900.
2021.
Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1
Leave a comment here